� � �6 Changes in insulin regimen including, strength, manufacturer, type, injection site or method of administration may result in the need for a change in insulin dose or an adjustment in concomitant oral antidiabetic treatment.Repeated insulin injections into areas of lipodystrophy or localized cutaneous amyloidosis may result in hyperglycemia; sudden change in the injection site (to unaffected area) has been reported to result in hypoglycemia. To help ensure an accurate dose each time, patients should follow all steps in the Instruction Leaflet accompanying the pen: otherwise they may not get the correct amount of insulin, which may affect their blood glucose.Toujeo is a long-acting human insulin analog indicated to improve glycemic control in adults and pediatric patients 6 years and older with diabetes mellitus.Limitations of Use: Toujeo is not recommended for treating diabetic ketoacidosis.Toujeo is contraindicated during episodes of hypoglycemia and in patients hypersensitive to insulin glargine or any of its excipients.Toujeo contains the same active ingredient, insulin glargine, as LantusMonitor blood glucose in all patients treated with insulin. Medication errors, such as accidental mix-ups between basal insulin products and other insulins, particularly rapid-acting insulins, have been reported.

Not recommended for use in combination with any other product containing a GLP-1 receptor agonist. Do not administer Lantus via an insulin pump or intravenously because severe hypoglycemia can occur.Hypoglycemia is the most common adverse reaction of insulin therapy, including Lantus, and may be life-threatening. Proper management of your blood sugar, particularly as you describe, is beyond the scope of this forum. Closely monitor potassium levels in patients at risk of hypokalemia and treat if indicated.Fluid retention, which may lead to or exacerbate heart failure, can occur with concomitant use of thiazolidinediones (TZDs) with insulin. Changes in insulin regimen including, strength, manufacturer, type, injection site or method of administration may result in the need for a change in insulin dose or an adjustment in concomitant oral antidiabetic treatment.Repeated insulin injections into areas of lipodystrophy or localized cutaneous amyloidosis may result in hyperglycemia; sudden change in the injection site (to unaffected area) has been reported to result in hypoglycemia. If mixed or diluted, the solution may become cloudy, and the onset of action/time to peak effect may be altered in an unpredictable manner.

Lantus (insulin glargine) is only given once per day (not 3 times/day). These medicines help keep your blood glucose level from going expensive after you eat. It happens. Stomach absorption rate was too fast. Untreated hypokalemia may cause respiratory paralysis, ventricular arrhythmia, and death. It is especially important to perform a safety test when a patient is using a new pen for the first time.Do not withdraw Toujeo from the SoloStar and Max SoloStar single-patient-use prefilled pens with a syringe.SOLIQUA 100/33 is a combination of a long-acting human insulin analog with a glucagon-like peptide-1 (GLP-1) receptor agonist (RA) indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. You were looking forLantus Dose Calculator? Too low a blood sugar is more hazardous than too high overnight ... Hi.

30 years experience Endocrinology. They may make you feel less hungry and assist you lose some weight. ������5p�� �O'��O�ͤW/��I/��l���|�g�y���i��@-g#-HF d���.�2�]��M�s@)��%�p�^*�.ʩ>� ��^��˽�a�� When changing from another basal insulin to Toujeo, patients experienced higher average fasting plasma glucose levels in the first few weeks of therapy until titrated to their individualized fasting plasma glucose targets.

July 21, 2017 by DiabetesBro. I would not recommend taking the morning medicine at bedtime and then going to sleep. Not for treatment of type 1 diabetes mellitus or diabetic ketoacidosis. Advise patients to rotate injection site to unaffected areas and closely monitor for hypoglycemia.Do not dilute or mix Lantus with any other insulin or solution.